Clinical trial Recruiting at 1 site Observational Ages 18 and up

Danang Cerebral Venous Thrombosis Registry

Official title: A Prospective Registry of Patients With Cerebral Venous Thrombosis at Da Nang Hospital: Clinical Characteristics, Imaging Manifestations, and Functional Outcomes

Run by Da Nang Hospital · NCT07890675 · Data updated 2026-11-12

This registry collects information on adults with cerebral venous thrombosis admitted to Danang Hospital to see how the condition presents, what imaging shows, risk factors, and how patients recover.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment110 (estimated)
SponsorDa Nang Hospital
Academic / other
Locations1 site (Da Nang, Da Nang)
StatusRecruiting
StartedOctober 9, 2025
Main results expectedOctober 9, 2028
Study endsJuly 1, 2029
Registry record updatedOctober 26, 2026
Trial IDNCT07890675 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with definite CVT diagnosed by radiologic imaging and admitted to Danang Hospital, with consent and willingness to participate in follow-up.

Probably not a fit

Patients without CVT or those unable to complete follow-up may not benefit from the registry data.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective registry of adults with cerebral venous thrombosis at Da Nang Hospital. It collects standardized data on demographics, risk factors, clinical presentation, lab results, and neuroimaging findings (CTV/MRV) and tracks treatment and short-term outcomes during hospitalization and at follow-up. The study aims to describe the clinical spectrum, imaging patterns, etiologies, and functional recovery in this Vietnamese population. Standard anticoagulant therapy is used for management, and inclusion requires confirmed CVT and informed consent. Data will be analyzed to identify patterns and potential prognostic indicators in this setting.

Why it matters

Potential benefit: Understanding real-world CVT in central Vietnam could improve diagnosis and management, potentially improving outcomes for future patients.

How similar studies have gone: Observational CVT registries in other settings have provided valuable insights into presentation and outcomes, supporting the value of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18 years or older.
2. Definite diagnosis of cerebral venous thrombosis (CVT) confirmed by neuroimaging, including computed tomography venography (CTV), magnetic resonance venography (MRV), or digital subtraction angiography (DSA).
3. Admitted to Danang Hospital for acute or subacute management.
4. Patient or legally authorized representative provides written informed consent to participate in the registry.

Exclusion Criteria:

1. Non-thrombotic occlusion of cerebral veins or sinuses (e.g., direct tumor invasion, vascular malformation, or extrinsic mechanical compression without thrombosis).
2. Pre-existing advanced terminal illness or severe co-morbid condition with a life expectancy of less than 6 months prior to CVT presentation (e.g., end-stage malignancy, advanced organ failure).
3. pre-stroke modified Rankin Scale (mRS) score ≥ 2
4. Inability or refusal of the patient or their legal representative to complete the 6-month follow-up assessment.
5. Refusal to provide informed consent.

Where it's running

  • Da Nang Hospital
    Da Nang, Da Nang, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.